Patents by Inventor Margaret N. Whitacre

Margaret N. Whitacre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100196310
    Abstract: The present invention relates generally to the use of human IL-18 combinations in the treatment of various forms of solid tumors and lymphomas. In particular, the present invention relates to: (1) combinations of human IL-18 with monoclonal antibodies against antigens that are expressed on the surface of cancer cells; and (2) combinations of human IL-18 with chemotherapeutic agents.
    Type: Application
    Filed: March 20, 2008
    Publication date: August 5, 2010
    Applicant: SMITHKLINE BEECHAM CORPORATION
    Inventors: Zdenka Haskova, Zdenka Ludmila Jonak, Stephen H. Trulli, Margaret N. Whitacre
  • Publication number: 20100111945
    Abstract: The present invention relates generally to the use of human IL-18 combinations in the treatment of cancers. In particular, the present invention relates to combination of human IL-18 and an anti-CD20 antibody.
    Type: Application
    Filed: March 20, 2008
    Publication date: May 6, 2010
    Inventors: Zdenka Haskova, Zdenka Ludmila Jonak, Stephen H. Trulli, John F. Toso, Margaret N. Whitacre
  • Publication number: 20090035258
    Abstract: The present invention relates generally to the use of human IL-18 combinations in the treatment of various forms of solid tumors and lymphomas. In particular, the present invention relates to: (1) combinations of human IL-18 with monoclonal antibodies against antigens that are expressed on the surface of cancer cells; and (2) combinations of human IL-18 with chemotherapeutic agents.
    Type: Application
    Filed: March 20, 2008
    Publication date: February 5, 2009
    Inventors: Zdenka Haskova, Zdenka Ludmila Jonak, Stephen H. Trulli, Margaret N. Whitacre
  • Publication number: 20080274078
    Abstract: The present invention relates generally to the use of human IL-18 combinations in the treatment of cancers. In particular, the present invention relates to combination of human IL-18 and an anti-CD20 antibody.
    Type: Application
    Filed: March 20, 2008
    Publication date: November 6, 2008
    Inventors: Zdenka HASKOVA, Zdenka Ludmila JONAK, Stephen H. TRULLI, John F. TOSO, Margaret N. WHITACRE